Table 2 Brief details of patients positive for PCP by mtLSUrRNA PCR assay and negative by DHFR, DHPS PCR assay and microscopic examination.
From: Genetic polymorphisms associated with treatment failure and mortality in pediatric Pneumocystosis
S.No. | Age (yr)/sex** | Underlying conditions* | Respiratory sample | Fever | Cough | Dyspnea | CXR/CT-scan$ | Coinfections | Response@ |
|---|---|---|---|---|---|---|---|---|---|
1 | 0.08/M | Pneumonia | BALF | Yes | Dry | Yes | B/l infiltrates/GGO | M. tuberculosis | S |
2 | 1.5/M | Malnutrition/Pneumonia | Sputum | Yes | Dry | Yes | B/l infiltrates/GGO | No | S |
3 | 2/M | Cystic fibrosis/pneumonia | BALF | No | Dry | Yes | B/l infiltrates/GGO | Ps. aeruginosa | E |
4 | 4.5/M | Interstitial lung disease | Sputum | No | Expectorated | Yes | B/l infiltrates/NA | No | S |
5 | 5/M | Sarcoidosis | BALF | Yes | No cough | No | B/l hilar lymphadenopathy/NA | No | S |
6 | 5.5/M | Pneumonia | BALF | Yes | Dry | Yes | B/L infiltrates/NA | No | S |
7 | 7.42/M | Lymphoproliferative syndrome with severe pneumonia | BALF | Yes | Dry | Yes | B/L infiltrates/GGO | M. tuberculosis | E |
